The Centers for Medicare & Medicaid Services released three new HCPCS Level II codes related to bebtelovimab, which providers may order to treat COVID-19. The codes were effective Feb. 11, 2022, the date the Food and Drug Administration authorized the emergency use of bebtelovimab.
These codes are now available on Codify by AAPC: